508 related articles for article (PubMed ID: 9815262)
1. Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells.
Chen W; Jin W; Wahl SM
J Exp Med; 1998 Nov; 188(10):1849-57. PubMed ID: 9815262
[TBL] [Abstract][Full Text] [Related]
2. Polarization of naive CD4+ T cells toward the Th1 subset by CTLA-4 costimulation.
Kato T; Nariuchi H
J Immunol; 2000 Apr; 164(7):3554-62. PubMed ID: 10725710
[TBL] [Abstract][Full Text] [Related]
3. Lack of a role for transforming growth factor-beta in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation.
Sullivan TJ; Letterio JJ; van Elsas A; Mamura M; van Amelsfort J; Sharpe S; Metzler B; Chambers CA; Allison JP
Proc Natl Acad Sci U S A; 2001 Feb; 98(5):2587-92. PubMed ID: 11226283
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta mediates CTLA-4 suppression of cellular immunity in murine kalaazar.
Gomes NA; Gattass CR; Barreto-De-Souza V; Wilson ME; DosReis GA
J Immunol; 2000 Feb; 164(4):2001-8. PubMed ID: 10657651
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic T lymphocyte-associated antigen-4 inhibits integrin-mediated stimulation.
Gatta L; Calviello G; Di Nicuolo F; Pace L; Ubaldi V; Doria G; Pioli C
Immunology; 2002 Oct; 107(2):209-16. PubMed ID: 12383200
[TBL] [Abstract][Full Text] [Related]
6. CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells.
Krummel MF; Allison JP
J Exp Med; 1996 Jun; 183(6):2533-40. PubMed ID: 8676074
[TBL] [Abstract][Full Text] [Related]
7. The inhibitory effects of transforming growth factor-beta-1 (TGF-beta1) in autoimmune diseases.
Prud'homme GJ; Piccirillo CA
J Autoimmun; 2000 Feb; 14(1):23-42. PubMed ID: 10648114
[TBL] [Abstract][Full Text] [Related]
8. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
Broeren CP; Gray GS; Carreno BM; June CH
J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxic T lymphocyte antigen 4 (CTLA-4) engagement delivers an inhibitory signal through the membrane-proximal region in the absence of the tyrosine motif in the cytoplasmic tail.
Nakaseko C; Miyatake S; Iida T; Hara S; Abe R; Ohno H; Saito Y; Saito T
J Exp Med; 1999 Sep; 190(6):765-74. PubMed ID: 10499915
[TBL] [Abstract][Full Text] [Related]
10. Cytotoxic T lymphocyte antigen 4 (CTLA-4) inhibits CD28-induced IkappaBalpha degradation and RelA activation.
Pioli C; Gatta L; Frasca D; Doria G
Eur J Immunol; 1999 Mar; 29(3):856-63. PubMed ID: 10092088
[TBL] [Abstract][Full Text] [Related]
11. The role of CTLA-4 in regulating Th2 differentiation.
Oosterwegel MA; Mandelbrot DA; Boyd SD; Lorsbach RB; Jarrett DY; Abbas AK; Sharpe AH
J Immunol; 1999 Sep; 163(5):2634-9. PubMed ID: 10453003
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) can regulate dendritic cell-induced activation and cytotoxicity of CD8(+) T cells independently of CD4(+) T cell help.
McCoy KD; Hermans IF; Fraser JH; Le Gros G; Ronchese F
J Exp Med; 1999 Apr; 189(7):1157-62. PubMed ID: 10190907
[TBL] [Abstract][Full Text] [Related]
13. B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4).
Mandelbrot DA; McAdam AJ; Sharpe AH
J Exp Med; 1999 Jan; 189(2):435-40. PubMed ID: 9892625
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta requires CTLA-4 early after T cell activation to induce FoxP3 and generate adaptive CD4+CD25+ regulatory cells.
Zheng SG; Wang JH; Stohl W; Kim KS; Gray JD; Horwitz DA
J Immunol; 2006 Mar; 176(6):3321-9. PubMed ID: 16517699
[TBL] [Abstract][Full Text] [Related]
15. Non-responsiveness of antigen-experienced CD4 T cells reflects more stringent co-stimulatory requirements.
Hamel ME; Noteboom E; Kruisbeek AM
Immunology; 1998 Mar; 93(3):366-75. PubMed ID: 9640247
[TBL] [Abstract][Full Text] [Related]
16. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation.
Krummel MF; Allison JP
J Exp Med; 1995 Aug; 182(2):459-65. PubMed ID: 7543139
[TBL] [Abstract][Full Text] [Related]
17. Blockade of T cell activation using a surface-linked single-chain antibody to CTLA-4 (CD152).
Griffin MD; Hong DK; Holman PO; Lee KM; Whitters MJ; O'Herrin SM; Fallarino F; Collins M; Segal DM; Gajewski TF; Kranz DM; Bluestone JA
J Immunol; 2000 May; 164(9):4433-42. PubMed ID: 10779742
[TBL] [Abstract][Full Text] [Related]
18. A novel costimulation pathway via the 4C8 antigen for the induction of CD4+ regulatory T cells.
Masuyama J; Kaga S; Kano S; Minota S
J Immunol; 2002 Oct; 169(7):3710-6. PubMed ID: 12244164
[TBL] [Abstract][Full Text] [Related]
19. ICOS costimulation requires IL-2 and can be prevented by CTLA-4 engagement.
Riley JL; Blair PJ; Musser JT; Abe R; Tezuka K; Tsuji T; June CH
J Immunol; 2001 Apr; 166(8):4943-8. PubMed ID: 11290772
[TBL] [Abstract][Full Text] [Related]
20. Cell contact-dependent immunosuppression by CD4(+)CD25(+) regulatory T cells is mediated by cell surface-bound transforming growth factor beta.
Nakamura K; Kitani A; Strober W
J Exp Med; 2001 Sep; 194(5):629-44. PubMed ID: 11535631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
